All these findings indicated that the single transcription factor ASCL1 could also reprogram human glioma cells into terminally differentiated neurons in vivo, which contributed to blocking the aggressive proliferation of human glioma cells and inhibiting their tumorigenicity in the brain. The gene discussed is ASCL1; the disease is central nervous system cancer.